ATAD5
Basic information
Region (hg38): 17:30831966-30895869
Previous symbols: [ "C17orf41" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (183 variants)
- ATAD5-related_disorder (25 variants)
- not_provided (13 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATAD5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000024857.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 15 | ||||
missense | 170 | 16 | 190 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
Total | 0 | 0 | 170 | 27 | 9 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATAD5 | protein_coding | protein_coding | ENST00000321990 | 23 | 63900 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000282 | 125733 | 0 | 11 | 125744 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.89 | 725 | 883 | 0.821 | 0.0000425 | 12213 |
Missense in Polyphen | 108 | 198.24 | 0.54479 | 2834 | ||
Synonymous | 2.08 | 267 | 314 | 0.851 | 0.0000158 | 3339 |
Loss of Function | 7.09 | 9 | 75.4 | 0.119 | 0.00000390 | 1111 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000273 | 0.000268 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000370 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000371 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in DNA damage response. Involved in a RAD9A- related damage checkpoint, a pathway that is important in determining whether DNA damage is compatible with cell survival or whether it requires cell elimination by apoptosis. Modulates the RAD9A interaction with BCL2 and thereby induces DNA damages- induced apoptosis. {ECO:0000269|PubMed:15983387}.;
Intolerance Scores
- loftool
- 0.372
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 48.95
Haploinsufficiency Scores
- pHI
- 0.368
- hipred
- Y
- hipred_score
- 0.704
- ghis
- 0.592
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.590
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Atad5
- Phenotype
- hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- positive regulation of B cell proliferation;nuclear DNA replication;B cell proliferation;signal transduction in response to DNA damage;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;isotype switching;positive regulation of DNA replication;positive regulation of isotype switching to IgG isotypes;nucleic acid phosphodiester bond hydrolysis;DNA clamp unloading;regulation of mitotic cell cycle phase transition;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of cell cycle G2/M phase transition
- Cellular component
- nucleus;Elg1 RFC-like complex
- Molecular function
- DNA binding;protein binding;ATP binding;DNA clamp unloader activity